Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2002
04/23/2002US6376526 For huans, animals
04/23/2002US6376515 Benzamides and related inhibitors of factor Xa
04/23/2002US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases
04/23/2002US6376512 Therapeutic uses of quinoline derivatives
04/23/2002US6376507 NK-1 receptor antagonists for the treatment of neuronal injury and stroke
04/23/2002US6376506 Sulfamide-metalloprotease inhibitors
04/23/2002US6376503 Alpha 1a adrenergic receptor antagonists
04/23/2002US6376500 Substituted 2-(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones
04/23/2002US6376499 Piperazine-amide compound with anticoagulant activity
04/23/2002US6376493 Selective inhibition of phosphodiesterase iv and tumor necrosis factor; useful in treating osteoporosis, tumors, autoimmune diseases, rheumatic diseases, and asthma
04/23/2002US6376492 Compounds and methods for inhibition of HIV and related viruses
04/23/2002US6376490 Strong n-methyl-d-asparate receptor antagonists; useful in treating strokes, ischemia, and central nervous system injuries
04/23/2002US6376484 For prevention and/or treatment of various kinds of inflammatory disease
04/23/2002US6376472 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
04/23/2002CA2282480C Process for the preparation of 10,11-dihydro-5h-dibenzo[a,d]cyclohept-5-enes and derivatives thereof
04/23/2002CA2263353C Arylsulfonylimidazolone derivatives as an antitumor agent
04/23/2002CA2246727C Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
04/23/2002CA2223403C Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds
04/23/2002CA2069144C Imidazole compounds, their preparation and use
04/20/2002CA2359383A1 Use of pdev inhibitors for improved fecundity in mammals
04/18/2002WO2002031056A1 Cationic imidazole azo dyes
04/18/2002WO2002030929A1 Novel pleuromutilin derivatives
04/18/2002WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
04/18/2002WO2002030924A1 Quinazoline derivatives with anti-tumour activity
04/18/2002WO2002030923A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
04/18/2002WO2002030921A1 Herbicidally active pyridine sulfonyl urea derivatives
04/18/2002WO2002030912A1 Benzodiazepine derivatives as inhibitors of gamma secretase
04/18/2002WO2002030911A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002WO2002030908A1 Inhibitors of protein kinases
04/18/2002WO2002030907A1 Pyrazole derivatives for the treatment of viral diseases
04/18/2002WO2002030904A1 Pyridinone derivatives for treatment of atherosclerosis
04/18/2002WO2002030898A1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists
04/18/2002WO2002030897A2 Compositions and methods for regulating the nervous system
04/18/2002WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS
04/18/2002WO2002030892A1 Butenolide and pentenolide derivatives as kinase inhibitors
04/18/2002WO2002030890A1 Nitrogenous five-membered ring compounds
04/18/2002WO2002030881A1 Sulfonylguanidine
04/18/2002WO2002030558A2 A linker and a method of chemical synthesis
04/18/2002WO2002030426A1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
04/18/2002WO2002030405A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
04/18/2002WO2002030374A1 Method of dyeing keratin-containing fibres
04/18/2002WO2002012166A3 Triamine derivative melanocortin receptor ligands and methods of using same
04/18/2002WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/18/2002WO2002000624A3 Methods and compounds for inhibiting mrp1
04/18/2002WO2001085715A3 Aza- and polyazanthranyl amides and their use as medicaments
04/18/2002WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors
04/18/2002WO2000066106A9 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
04/18/2002US20020045758 1-arylpyrazole oxime derivatives; safe systemic insecticides for control of arthropod, nematode, helminth or protozoan pests
04/18/2002US20020045757 Compound and process for producing beta-adrenergic receptor agonist
04/18/2002US20020045654 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
04/18/2002US20020045651 Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones
04/18/2002US20020045647 N-linked urea or carbamate of heterocyclic thioester hair growth compositons and uses
04/18/2002US20020045646 Pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors with fast acting buffer; gastric acid stability for enteral administration
04/18/2002US20020045643 Isoindolines, method of use, and pharmaceutical compositions
04/18/2002US20020045642 Antiinflammatory, -arthritic and -emetic agents; central nervous system disorders; Parkinson's disease; antidepressants; psychological disorders; anxiolytic agents; antagonists of substance P receptors
04/18/2002US20020045641 Multiple heteroatom containing heterocyclic ring compounds substituted with carboxylic acids and isosteres thereof
04/18/2002US20020045628 Antidepressants; anxiolytic agents; serotonin-affected nervous system disorders; acting at the 5-HT1a autoreceptors concommitantly with 5-HT transporters; antiserotonin agents; serotonin reuptake inhibitors; HT3 receptor antagonists
04/18/2002US20020045626 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
04/18/2002US20020045618 Heteroaryl diazacycloalkanes, their preparation and use
04/18/2002US20020045614 1-(4-(((4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino) methyl)-4-phenyl-piperidin-1-yl)-1-cyclopropyl-methanone; treating disease states ameliorated by blockade of alpha-1 adrenoceptors; sleep/psychological disorders
04/18/2002US20020045613 1-aroyl-piperidinyl benzamidines
04/18/2002US20020045206 Contacting the cells with a trophic amount of a ptc therapeutic for promoting survival of substantia nigra neuronal cells
04/18/2002US20020044899 Controlled, super-fine grinding so particles react completely during leaching; extraction of copper from copper sulfide ores and concentrates
04/18/2002DE10048716A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site
04/18/2002DE10047116A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines
04/18/2002CA2459746A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002CA2427499A1 Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-.gamma. binding agents
04/18/2002CA2425416A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
04/18/2002CA2424812A1 Benzodiazepine derivatives as inhibitors of gamma secretase
04/18/2002CA2424802A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
04/18/2002CA2424107A1 Sulfonylguanidines
04/18/2002CA2423515A1 Pyrazole derivatives for the treatment of viral diseases
04/18/2002CA2394084A1 Inhibitors of protein kinases
04/17/2002EP1197493A1 Benzimidazole compounds
04/17/2002EP1197492A1 Pyrazole derivatives and process for producing the same, and pesticides containing the same as the active ingredient
04/17/2002EP1197487A1 Benzimidazole compounds and drugs containing the same
04/17/2002EP1197485A1 Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
04/17/2002EP1196500A1 Reactive dye compounds
04/17/2002EP1196412A1 Nitrogen containing heterobicycles as factor xa inhibitors
04/17/2002EP1196411A1 Bradykinin b1 receptor antagonists
04/17/2002EP1196410A1 Respiratory syncytial virus replication inhibitors
04/17/2002EP1196409A2 Respiratory syncytial virus replication inhibitors
04/17/2002EP1196408A1 Respiratory syncytial virus replication inhibitors
04/17/2002EP1196407A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors
04/17/2002EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity
04/17/2002EP1196400A1 Amino-alkyl derivatives
04/17/2002EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
04/17/2002EP1196396A1 Conjugates of sodium channel blockers and methods of using the same
04/17/2002EP1196394A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists
04/17/2002EP1196392A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof
04/17/2002EP1196391A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors
04/17/2002EP1196390A2 Pyrazole compositions useful as inhibitors of erk
04/17/2002EP1196389A1 N-heterocyclic derivatives with neuronal activity
04/17/2002EP1196388A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
04/17/2002EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
04/17/2002EP1196380A2 Indoles and indazoles for the treatment of migraine
04/17/2002EP1196379A2 INHIBITORS OF FACTOR Xa
04/17/2002EP1196169A1 Compounds having cytokine inhibitory activity
04/17/2002EP1196167A1 Method of reducing neuronal injury or apoptosis
04/17/2002EP1196165A2 Azetidine compounds in cns and eye diseases